On December 25-26, 2021, the 13th China Minimally Invasive Interventional Medicine Academic Conference (2021 CMIC) & New Technology Training Class of Minimally Invasive Diagnosis and Treatment were grandly held in Beijing, and the  High Voltage Steep Pulse Minimally Invasive Therapeutic System of Alpmed made a public appearance at the conference.

As a  treatment with significant advantages and leading edge in the minimally invasive field, the steep pulse irreversible electroporation technology is being developed rapidly by numerous domestic medical enterprises, and is accelerating from high-end medical treatment to public medical treatment, bringing hope to many patients who previously could not access this treatment.

Under the leadership of Professor Zheng Jiasheng's team, the Minimally Invasive Intervention Committee adheres to the principle of combining research and teaching.The committee not only organized multi-level training courses at academic conferences, but also initiated the preparation work of the Irreversible Electroporation Special Committee under the CMIC framework, striving to better serve Chinese patients with steep pulse technology.

As the first domestic research and development and production enterprise approved for the minimally invasive treatment of liver malignant tumors using steep pulse technology, Alpmed's mission is "innovation for hope." Since 2013, Alpmed has invested nearly 100 million yuan over eight years, and its professional team has devoted themselves to researching and developing the High Voltage Steep Pulse Minimally Invasive Therapeutic System, which has multiple independent intellectual property rights. Whether it is the stability control of the energy field or the multiple parameter monitoring functions provided during the treatment process, the system is superior to imported products. As the first company in China to obtain the medical device production license from the National Medical Products Administration in the field of liver malignant solid tumor treatment, we will continue to improve product performance and expand product lines, and create a new image of high-precision medical manufacturing in China that meets international standards.

During the satellite meeting of irreversible electroporation technology, Li Yanping, the marketing manager of Alpmed, introduced the technical features of the High Voltage  Steep Pulse Therapeutic Apparatus: stable energy output of 1000v-3000v, precise algorithm of electrocardiogram synchronization technology, real-time display of multiple treatment parameters, and an insulated sleeve electrode design that can adjust the exposure depth. These features provide comprehensive support for the surgeon's surgical skills and

patients’ safety from multiple perspectives.

During the satellite conference, Professor Zheng Jiasheng shared process in using the High Voltage Steep Pulse Minimally Invasive Therapeutic System to treat various cases with rigorous scientific research attitude, as well as his feelings about using this system.He proudly talked about several cases of malignant tumors such as liver cancer that he had treated, and how the patients' survival time had significantly increased and their quality of life had improved. Finally, he summarized his recognition and praise for the High Voltage Steep Pulse Minimally Invasive Therapeutic System.